» Articles » PMID: 33927272

Calcium Carbonate Nanoparticles Stimulate Cancer Cell Reprogramming to Suppress Tumor Growth and Invasion in an Organ-on-a-chip System

Overview
Journal Sci Rep
Specialty Science
Date 2021 Apr 30
PMID 33927272
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The acidic microenvironment of solid tumors induces the propagation of highly invasive and metastatic phenotypes. However, simulating these conditions in animal models present challenges that confound the effects of pH modulators on tumor progression. To recapitulate the tumor microenvironment and isolate the effect of pH on tumor viability, we developed a bifurcated microfluidic device that supports two different cell environments for direct comparison. RFP-expressing breast cancer cells (MDA-MB-231) were cultured in treatment and control chambers surrounded by fibrin, which received acid-neutralizing CaCO nanoparticles (nanoCaCO) and cell culture media, respectively. Data analysis revealed that nanoCaCO buffered the pH within the normal physiological range and inhibited tumor cell proliferation compared to the untreated control (p < 0.05). Co-incubation of cancer cells and fibroblasts, followed by nanoCaCO treatment showed that the nanoparticles selectively inhibited the growth of the MDA-MB-231 cells and reduced cellular migration of these cells with no impact on the fibroblasts. Sustainable decrease in the intracellular pH of cancer cells treated with nanoCaCO indicates that the extracellular pH induced cellular metabolic reprogramming. These results suggest that the nanoCaCO can restrict the aggressiveness of tumor cells without affecting the growth and behavior of the surrounding stromal cells.

Citing Articles

Lactate and lactylation in cancer.

Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y Signal Transduct Target Ther. 2025; 10(1):38.

PMID: 39934144 PMC: 11814237. DOI: 10.1038/s41392-024-02082-x.


Improving tumor microenvironment assessment in chip systems through next-generation technology integration.

Gaebler D, Hachey S, Hughes C Front Bioeng Biotechnol. 2024; 12:1462293.

PMID: 39386043 PMC: 11461320. DOI: 10.3389/fbioe.2024.1462293.


Targeted Cancer Therapy-on-A-Chip.

Abed H, Radha R, Anjum S, Paul V, AlSawaftah N, Pitt W Adv Healthc Mater. 2024; 13(29):e2400833.

PMID: 39101627 PMC: 11582519. DOI: 10.1002/adhm.202400833.


Multiplex, high-throughput method to study cancer and immune cell mechanotransduction.

Fabiano A, Robbins S, Knoblauch S, Rowland S, Dombroski J, King M Commun Biol. 2024; 7(1):674.

PMID: 38824207 PMC: 11144229. DOI: 10.1038/s42003-024-06327-x.


Functionalized Calcium Carbonate-Based Microparticles as a Versatile Tool for Targeted Drug Delivery and Cancer Treatment.

Biny L, Gerasimovich E, Karaulov A, Sukhanova A, Nabiev I Pharmaceutics. 2024; 16(5).

PMID: 38794315 PMC: 11124899. DOI: 10.3390/pharmaceutics16050653.


References
1.
Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View

2.
Takahashi E, Yamaguchi D, Yamaoka Y . A Relatively Small Gradient of Extracellular pH Directs Migration of MDA-MB-231 Cells In Vitro. Int J Mol Sci. 2020; 21(7). PMC: 7177698. DOI: 10.3390/ijms21072565. View

3.
Chen D, Tang Q, Zou J, Yang X, Huang W, Zhang Q . pH-Responsive PEG-Doxorubicin-Encapsulated Aza-BODIPY Nanotheranostic Agent for Imaging-Guided Synergistic Cancer Therapy. Adv Healthc Mater. 2018; 7(7):e1701272. DOI: 10.1002/adhm.201701272. View

4.
Lam S, Shirure V, Chu Y, Soetikno A, George S . Microfluidic device to attain high spatial and temporal control of oxygen. PLoS One. 2018; 13(12):e0209574. PMC: 6301786. DOI: 10.1371/journal.pone.0209574. View

5.
Ueno Y, Futagawa H, Takagi Y, Ueno A, Mizushima Y . Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J Control Release. 2005; 103(1):93-8. DOI: 10.1016/j.jconrel.2004.11.015. View